The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cells in whole blood in suspension; this makes plasma the extracellular matrix of blood cells.
Global Platelet and Plasma market is projected to reach US$ 5836.7 million in 2029, increasing from US$ 5081.2 million in 2022, with the CAGR of 2.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Platelet and Plasma market research.
Platelets have no cell nucleus: they are fragments of cytoplasm that are derived from the megakaryocytes of the bone marrow, and then enter the circulation. Circulating unactivated platelets are biconvex discoid (lens-shaped) structures,2–3 µm in greatest diameter. Platelets are found only in mammals, whereas in other animals (e.g. birds, amphibians) thrombocytes circulate as intact mononuclear cells. Plasma makes up about 55% of the body's total blood volume.It is the intravascular fluid part of extracellular fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and contains dissolved proteins (6–8%) (i.e.—serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3−, Cl−, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation) and oxygen. Plasma also serves as the protein reserve of the human body. It plays a vital role in an intravascular osmotic effect that keeps electrolytes in balanced form and protects the body from infection and other blood disorders. Rising prevalence of chronic diseases such as haemophilia, thrombocytopenia, haemorrhage, liver diseases as well as other rare and infectious diseases will drive the global platelet and plasma market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Platelet and Plasma market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- America’s Blood Centers
- American Red Cross
- American Association of Blood Banks
- Blood Centers of America
- Brazilian Red Cross
- Canadian Red Cross
- European Blood Alliance
- French Red Cross
- German Red Cross
- Indian Red Cross
- Italian Red Cross
- Red Cross Society of China
- Saudi Red Crescent Authority
- South African Red Cross Society
Segment by Type
- Platelet
- Plasma
Segment by Application
- Hosptials
- Clinics
- Ambulatory Surgical Centres
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Platelet and Plasma report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet and Plasma Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Platelet
1.2.3 Plasma
1.3 Market by Application
1.3.1 Global Platelet and Plasma Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hosptials
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Platelet and Plasma Market Perspective (2018-2029)
2.2 Platelet and Plasma Growth Trends by Region
2.2.1 Global Platelet and Plasma Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Platelet and Plasma Historic Market Size by Region (2018-2023)
2.2.3 Platelet and Plasma Forecasted Market Size by Region (2024-2029)
2.3 Platelet and Plasma Market Dynamics
2.3.1 Platelet and Plasma Industry Trends
2.3.2 Platelet and Plasma Market Drivers
2.3.3 Platelet and Plasma Market Challenges
2.3.4 Platelet and Plasma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Platelet and Plasma Players by Revenue
3.1.1 Global Top Platelet and Plasma Players by Revenue (2018-2023)
3.1.2 Global Platelet and Plasma Revenue Market Share by Players (2018-2023)
3.2 Global Platelet and Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Platelet and Plasma Revenue
3.4 Global Platelet and Plasma Market Concentration Ratio
3.4.1 Global Platelet and Plasma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet and Plasma Revenue in 2022
3.5 Platelet and Plasma Key Players Head office and Area Served
3.6 Key Players Platelet and Plasma Product Solution and Service
3.7 Date of Enter into Platelet and Plasma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Platelet and Plasma Breakdown Data by Type
4.1 Global Platelet and Plasma Historic Market Size by Type (2018-2023)
4.2 Global Platelet and Plasma Forecasted Market Size by Type (2024-2029)
5 Platelet and Plasma Breakdown Data by Application
5.1 Global Platelet and Plasma Historic Market Size by Application (2018-2023)
5.2 Global Platelet and Plasma Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Platelet and Plasma Market Size (2018-2029)
6.2 North America Platelet and Plasma Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Platelet and Plasma Market Size by Country (2018-2023)
6.4 North America Platelet and Plasma Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Platelet and Plasma Market Size (2018-2029)
7.2 Europe Platelet and Plasma Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Platelet and Plasma Market Size by Country (2018-2023)
7.4 Europe Platelet and Plasma Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Platelet and Plasma Market Size (2018-2029)
8.2 Asia-Pacific Platelet and Plasma Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Platelet and Plasma Market Size by Region (2018-2023)
8.4 Asia-Pacific Platelet and Plasma Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Platelet and Plasma Market Size (2018-2029)
9.2 Latin America Platelet and Plasma Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Platelet and Plasma Market Size by Country (2018-2023)
9.4 Latin America Platelet and Plasma Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Platelet and Plasma Market Size (2018-2029)
10.2 Middle East & Africa Platelet and Plasma Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Platelet and Plasma Market Size by Country (2018-2023)
10.4 Middle East & Africa Platelet and Plasma Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 America’s Blood Centers
11.1.1 America’s Blood Centers Company Detail
11.1.2 America’s Blood Centers Business Overview
11.1.3 America’s Blood Centers Platelet and Plasma Introduction
11.1.4 America’s Blood Centers Revenue in Platelet and Plasma Business (2018-2023)
11.1.5 America’s Blood Centers Recent Development
11.2 American Red Cross
11.2.1 American Red Cross Company Detail
11.2.2 American Red Cross Business Overview
11.2.3 American Red Cross Platelet and Plasma Introduction
11.2.4 American Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.2.5 American Red Cross Recent Development
11.3 American Association of Blood Banks
11.3.1 American Association of Blood Banks Company Detail
11.3.2 American Association of Blood Banks Business Overview
11.3.3 American Association of Blood Banks Platelet and Plasma Introduction
11.3.4 American Association of Blood Banks Revenue in Platelet and Plasma Business (2018-2023)
11.3.5 American Association of Blood Banks Recent Development
11.4 Blood Centers of America
11.4.1 Blood Centers of America Company Detail
11.4.2 Blood Centers of America Business Overview
11.4.3 Blood Centers of America Platelet and Plasma Introduction
11.4.4 Blood Centers of America Revenue in Platelet and Plasma Business (2018-2023)
11.4.5 Blood Centers of America Recent Development
11.5 Brazilian Red Cross
11.5.1 Brazilian Red Cross Company Detail
11.5.2 Brazilian Red Cross Business Overview
11.5.3 Brazilian Red Cross Platelet and Plasma Introduction
11.5.4 Brazilian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.5.5 Brazilian Red Cross Recent Development
11.6 Canadian Red Cross
11.6.1 Canadian Red Cross Company Detail
11.6.2 Canadian Red Cross Business Overview
11.6.3 Canadian Red Cross Platelet and Plasma Introduction
11.6.4 Canadian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.6.5 Canadian Red Cross Recent Development
11.7 European Blood Alliance
11.7.1 European Blood Alliance Company Detail
11.7.2 European Blood Alliance Business Overview
11.7.3 European Blood Alliance Platelet and Plasma Introduction
11.7.4 European Blood Alliance Revenue in Platelet and Plasma Business (2018-2023)
11.7.5 European Blood Alliance Recent Development
11.8 French Red Cross
11.8.1 French Red Cross Company Detail
11.8.2 French Red Cross Business Overview
11.8.3 French Red Cross Platelet and Plasma Introduction
11.8.4 French Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.8.5 French Red Cross Recent Development
11.9 German Red Cross
11.9.1 German Red Cross Company Detail
11.9.2 German Red Cross Business Overview
11.9.3 German Red Cross Platelet and Plasma Introduction
11.9.4 German Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.9.5 German Red Cross Recent Development
11.10 Indian Red Cross
11.10.1 Indian Red Cross Company Detail
11.10.2 Indian Red Cross Business Overview
11.10.3 Indian Red Cross Platelet and Plasma Introduction
11.10.4 Indian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.10.5 Indian Red Cross Recent Development
11.11 Italian Red Cross
11.11.1 Italian Red Cross Company Detail
11.11.2 Italian Red Cross Business Overview
11.11.3 Italian Red Cross Platelet and Plasma Introduction
11.11.4 Italian Red Cross Revenue in Platelet and Plasma Business (2018-2023)
11.11.5 Italian Red Cross Recent Development
11.12 Red Cross Society of China
11.12.1 Red Cross Society of China Company Detail
11.12.2 Red Cross Society of China Business Overview
11.12.3 Red Cross Society of China Platelet and Plasma Introduction
11.12.4 Red Cross Society of China Revenue in Platelet and Plasma Business (2018-2023)
11.12.5 Red Cross Society of China Recent Development
11.13 Saudi Red Crescent Authority
11.13.1 Saudi Red Crescent Authority Company Detail
11.13.2 Saudi Red Crescent Authority Business Overview
11.13.3 Saudi Red Crescent Authority Platelet and Plasma Introduction
11.13.4 Saudi Red Crescent Authority Revenue in Platelet and Plasma Business (2018-2023)
11.13.5 Saudi Red Crescent Authority Recent Development
11.14 South African Red Cross Society
11.14.1 South African Red Cross Society Company Detail
11.14.2 South African Red Cross Society Business Overview
11.14.3 South African Red Cross Society Platelet and Plasma Introduction
11.14.4 South African Red Cross Society Revenue in Platelet and Plasma Business (2018-2023)
11.14.5 South African Red Cross Society Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
